Article
Flutamide metformin for post-menarcheal girls with preclinical ovarian androgen excess: evidence for differential response by androgen receptor genotype.
European journal of endocrinology - 1 Nov 2007
Ong Ken K, de Zegher Francis, López-Bermejo Abel, Dunger David B, Ibáñez Lourdes
Abstract excerpt
OBJECTIVE: Addition of androgen receptor (AR) blockade (flutamide) to insulin-sensitising therapy (metformin) may confer synergistic benefits in girls with hyperinsulinaemic androgen excess. We hypothesised that girls with shorter AR gene CAG repeat alleles, and thus greater receptor sensitivity, might benefit more from the addition of low-dose flutamide. DESIGN: Open randomised crossover study. METHODS: In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
